Top 5 Most Read RNS's on Vox Markets for Thursday 27th April 2023
Episode 1368, Apr 27, 2023, 06:42 AM
Top 5 Most Read RNS's on Vox Markets for Thursday 27th April 2023
1. Avacta Group #AVCT - First Patient Dosed in the US in AVA6000 Phase 1
Avacta Group announces that the first patient has been dosed in the US under its Investigational New Drug Application in Avacta's phase 1 multi-centre trial evaluating the safety and tolerability of AVA6000, a novel tumour targeted form of doxorubicin and Avacta's first therapeutic product based on its proprietary pre|CISION™ technology.
2. Greatland Gold #GGP - Havieron Exploration and Development Update
Greatland Gold plc (AIM:GGP) ("Greatland" or the "Company") is pleased to provide an exploration and development update for Havieron, its flagship gold-copper project located in the Paterson Province of Western Australia.
Highlights
§ Drilling results: drilling continues to intersect high grade gold and copper mineralisation within the SE Crescent Resource and outside the current Mineral Resource at the Eastern Breccia target. Recent results include:
- SE Crescent: 54m @ 8.5g/t Au & 0.32% Cu from 1,421m
- Eastern Breccia: 31.1m @ 4.9 g/t Au & 0.13 % Cu from 1,635m
3. Synairgen #SNG - 2022 Full Year Results
Completed further analysis of data accumulated from the more than 750 patients dosed to date with SNG001. Findings included:
o Development of stratification criteria to target specific populations in future trials;
o SNG001 reduced the risk of several recognised Long COVID symptoms;
o Evidence of accelerated viral clearance of rhinovirus from the lung in COPD patients; and
o Further demonstration of the well-tolerated safety profile of SNG001.
4. Novacyt S.A. #NCYT - Final Results
Group revenue for FY2022 was £21.0m, in line with guidance, (FY2021: £92.6m), due to the expected decline in COVID-19 related sales
Revenue from COVID-19 products in 2022 totalled £14.7m (FY2021: £84.0m)
Revenue for the non-COVID-19 portfolio in 2022 totalled £6.3m (FY2021: £8.6m).
Cash position at 31 December 2022 was £87.0m (2021: £101.7m) and the Company remains debt free
5. Mosman Oil & Gas #MSMN - Acquisition of Additional Acreage
Mosman Oil and Gas Limited has secured a new lease adjacent to the Cinnabar lease in Texas, USA. Mosman is the Operator and Mosman will have a 78% working interest.
The principal terms of the lease are:
1. Payment of USD 36,000 (AUD 54,000)
2. Initial term of eighteen months that may be extended by the drilling and production of a well. Whilst there is production, the lease would be "Held by Production"
3. A Royalty of 25% of gross production (which is standard in this part of Texas)
1. Avacta Group #AVCT - First Patient Dosed in the US in AVA6000 Phase 1
Avacta Group announces that the first patient has been dosed in the US under its Investigational New Drug Application in Avacta's phase 1 multi-centre trial evaluating the safety and tolerability of AVA6000, a novel tumour targeted form of doxorubicin and Avacta's first therapeutic product based on its proprietary pre|CISION™ technology.
2. Greatland Gold #GGP - Havieron Exploration and Development Update
Greatland Gold plc (AIM:GGP) ("Greatland" or the "Company") is pleased to provide an exploration and development update for Havieron, its flagship gold-copper project located in the Paterson Province of Western Australia.
Highlights
§ Drilling results: drilling continues to intersect high grade gold and copper mineralisation within the SE Crescent Resource and outside the current Mineral Resource at the Eastern Breccia target. Recent results include:
- SE Crescent: 54m @ 8.5g/t Au & 0.32% Cu from 1,421m
- Eastern Breccia: 31.1m @ 4.9 g/t Au & 0.13 % Cu from 1,635m
3. Synairgen #SNG - 2022 Full Year Results
Completed further analysis of data accumulated from the more than 750 patients dosed to date with SNG001. Findings included:
o Development of stratification criteria to target specific populations in future trials;
o SNG001 reduced the risk of several recognised Long COVID symptoms;
o Evidence of accelerated viral clearance of rhinovirus from the lung in COPD patients; and
o Further demonstration of the well-tolerated safety profile of SNG001.
4. Novacyt S.A. #NCYT - Final Results
Group revenue for FY2022 was £21.0m, in line with guidance, (FY2021: £92.6m), due to the expected decline in COVID-19 related sales
Revenue from COVID-19 products in 2022 totalled £14.7m (FY2021: £84.0m)
Revenue for the non-COVID-19 portfolio in 2022 totalled £6.3m (FY2021: £8.6m).
Cash position at 31 December 2022 was £87.0m (2021: £101.7m) and the Company remains debt free
5. Mosman Oil & Gas #MSMN - Acquisition of Additional Acreage
Mosman Oil and Gas Limited has secured a new lease adjacent to the Cinnabar lease in Texas, USA. Mosman is the Operator and Mosman will have a 78% working interest.
The principal terms of the lease are:
1. Payment of USD 36,000 (AUD 54,000)
2. Initial term of eighteen months that may be extended by the drilling and production of a well. Whilst there is production, the lease would be "Held by Production"
3. A Royalty of 25% of gross production (which is standard in this part of Texas)